ETPrime

Ajanta Pharma Share Price

  • 2,603.604.70 (0.19%)
  • Volume: 84,248
  • Closed
  • Last Updated On: 16 May, 2025, 03:30 PM IST
  • 1D
  • 1W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Loading...
Ajanta Pharma Share Price
  • 2,603.604.70 (0.19%)
  • Volume: 84,248
Advertisment
Stock Recommendations

  • Potential
    Upside

  • 1 Year
    Target

BUY

Mean Recos by
11 Analysts

0

1

1

5

4

Strong Sell

Sell

Hold

Buy

Strong Buy

Unlock Potential Upside
Stock Reports Plus

/10

Stock Score

View Report
Earnings
Fundamentals
Relative Valuation
Risk
Price Momentum
No Rating (NR)
Negative
Neutral
Positive
Unlock Stock Score

Ajanta Pharma share price insights

  • Company has spent less than 1% of its operating revenues towards interest expenses and 23.44% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)

  • Ajanta Pharma Ltd. share price moved up by 0.19% from its previous close of Rs 2,598.90. Ajanta Pharma Ltd. stock last traded price is 2,603.60

    Share PriceValue
    Today/Current/Last2,603.60
    Previous Day2,598.902,597.15

InsightsAjanta Pharma

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Key Metrics

    PE Ratio
    (x)    		35.19
    EPS - TTM
    (₹)    		73.68
    MCap
    (₹ Cr.)    		32,385.96
    Sectoral MCap Rank
    		16
    PB Ratio
    (x)    		8.54
    Div Yield
    (%)    		1.08
    Face Value
    (₹)    		2.00
    Beta

    Beta

    1 Month-0.10
    3 Months0.53
    6 Months0.54
    1 Year0.88
    3 Years1.06

    		-0.10
    VWAP
    (₹)    		2,595.14
    52W H/L
    (₹)
    3,485.00 / 2,111.05

    Ajanta Pharma Share Price Returns

    1 Day0.19%
    1 Week2.59%
    1 Month-1.19%
    3 Months1.69%
    1 Year8.7%
    3 Years131.99%
    5 Years160.88%

    ET Stock ScreenersTop Score Companies

    Check whether Ajanta Pharma belongs to analysts' top-rated companies list?

    View Stock Screeners

    Ajanta Pharma News & Analysis

    View all Ajanta Pharma Share News & Announcements

    Ajanta Pharma Share Recommendations

    Recent Recos

    BUY

    Current

    Mean Recos by 11 Analysts

    Strong
    Sell    SellHoldBuyStrong
    Buy
    • Target₹2030
    • OrganizationICICI Securities
    • BUY
    • Target₹1580
    • OrganizationICICI Securities
    • BUY

    Analyst Trends

    RatingsCurrent1 Week Ago1 Month Ago3 Months Ago
    Strong Buy4443
    Buy5543
    Hold11--
    Sell1111
    Strong Sell--12
    # Analysts1111109
    View all Stock Recommendations

    Ajanta Pharma Financials

    • Insights

      • Employee & Interest Expense

        Company has spent less than 1% of its operating revenues towards interest expenses and 23.44% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)
      Quarterly | AnnualMar 2025Dec 2024Sep 2024Jun 2024Mar 2024
      Total Income1,188.521,176.571,206.121,171.391,089.58
      Total Income Growth (%)1.02-2.452.967.51-2.61
      Total Expenses913.04861.27909.86848.54810.01
      Total Expenses Growth (%)6.01-5.347.234.76-1.86
      EBIT275.48315.30296.26322.85279.57
      EBIT Growth (%)-12.636.43-8.2415.48-4.71
      Profit after Tax (PAT)225.26232.88216.48245.77202.72
      PAT Growth (%)-3.277.58-11.9221.24-3.48
      EBIT Margin (%)23.1826.8024.5627.5625.66
      Net Profit Margin (%)18.9519.7917.9520.9818.61
      Basic EPS (₹)18.0018.6017.2719.5416.10
      Quarterly | AnnualMar 2025Dec 2024Sep 2024Jun 2024Mar 2024
      Total Income1,031.871,135.151,169.251,105.64959.75
      Total Income Growth (%)-9.10-2.925.7515.20-12.67
      Total Expenses803.05800.52859.32794.36732.39
      Total Expenses Growth (%)0.32-6.848.188.46-7.47
      EBIT228.82334.63309.93311.28227.36
      EBIT Growth (%)-31.627.97-0.4336.91-26.06
      Profit after Tax (PAT)193.43252.45234.98236.03162.69
      PAT Growth (%)-23.387.43-0.4445.08-26.10
      EBIT Margin (%)22.1829.4826.5128.1523.69
      Net Profit Margin (%)18.7522.2420.1021.3516.95
      Basic EPS (₹)15.4620.1618.7518.7712.92
      Quarterly | Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Revenue4,742.604,293.313,841.283,456.672,915.67
      Total Revenue Growth (%)10.4611.7711.1318.558.79
      Total Expenses3,553.443,179.383,096.032,547.192,015.49
      Total Expenses Growth (%)11.772.6921.5526.380.16
      Profit after Tax (PAT)920.39816.17587.98712.68653.87
      PAT Growth (%)12.7738.81-17.508.9939.81
      Operating Profit Margin (%)26.0226.6320.0627.5231.43
      Net Profit Margin (%)19.8019.3915.7121.3322.62
      Basic EPS (₹)73.5664.8245.8982.4575.09
      Quarterly | Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Revenue4,441.914,087.603,544.023,280.372,822.16
      Total Revenue Growth (%)8.6715.348.0416.2418.55
      Total Expenses3,261.852,990.652,844.172,379.831,920.07
      Total Expenses Growth (%)9.075.1519.5123.948.85
      Profit after Tax (PAT)916.89807.24558.72719.86675.64
      PAT Growth (%)13.5844.48-22.386.5453.16
      Operating Profit Margin (%)27.4027.7920.6628.9633.43
      Net Profit Margin (%)21.2120.3216.3722.9224.85
      Basic EPS (₹)73.2864.1143.6183.2877.59

      All figures in Rs Cr, unless mentioned otherwise

      View Details
    • Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Assets5,014.954,638.394,679.024,055.583,778.72
      Total Assets Growth (%)8.12-0.8715.377.3313.86
      Total Liabilities1,224.661,071.031,291.03791.24783.09
      Total Liabilities Growth (%)14.34-17.0463.171.048.79
      Total Equity3,790.293,567.363,387.993,264.342,995.63
      Total Equity Growth (%)6.255.293.798.9715.27
      Current Ratio (x)2.853.052.493.503.13
      Total Debt to Equity (x)0.000.000.000.000.00
      Contingent Liabilities0.00161.3991.5276.44168.98
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Assets4,554.254,217.444,304.793,780.493,532.06
      Total Assets Growth (%)7.99-2.0313.877.0315.84
      Total Liabilities928.94803.871,058.34611.31647.08
      Total Liabilities Growth (%)15.56-24.0473.13-5.5310.08
      Total Equity3,625.313,413.573,246.453,169.182,884.98
      Total Equity Growth (%)6.205.152.449.8517.21
      Current Ratio (x)3.623.882.814.383.56
      Total Debt to Equity (x)0.000.000.000.000.00
      Contingent Liabilities0.00161.3991.5276.44168.98

      All figures in Rs Cr, unless mentioned otherwise

      View Details
    • Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Net Cash flow from Operating Activities1,157.23785.07791.78562.04576.31
      Net Cash used in Investing Activities-376.5265.39-559.60-74.10-282.39
      Net Cash flow from Financing Activities-733.41-1,051.06-107.87-460.04-318.29
      Net Cash Flow47.30-200.60124.3127.90-24.37
      Closing Cash & Cash Equivalent176.79129.23330.67205.41177.99
      Closing Cash & Cash Equivalent Growth (%)36.80-60.9260.9815.41-10.51
      Total Debt/ CFO (x)0.000.000.000.000.00
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Net Cash flow from Operating Activities1,053.80735.35736.29542.34466.99
      Net Cash used in Investing Activities-349.60105.02-501.31-66.04-162.68
      Net Cash flow from Financing Activities-715.71-1,047.70-105.12-457.30-268.90
      Net Cash Flow-11.51-207.33129.8619.0035.41
      Closing Cash & Cash Equivalent50.2761.52269.69138.88120.36
      Closing Cash & Cash Equivalent Growth (%)-18.29-77.1994.1915.3947.70
      Total Debt/ CFO (x)0.000.000.000.000.00

      All figures in Rs Cr, unless mentioned otherwise

      View Details
    • Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Return on Equity (%)24.2822.8717.3521.8321.82
      Return on Capital Employed (%)30.1029.9521.2126.9829.02
      Return on Assets (%)18.3517.5912.5617.5717.30
      Interest Coverage Ratio (x)65.32174.28151.01102.45123.89
      Asset Turnover Ratio (x)0.960.900.820.830.79
      Price to Earnings (x)35.7134.7226.0421.8323.87
      Price to Book (x)8.667.934.514.765.21
      EV/EBITDA (x)24.1122.4016.9514.6615.02
      EBITDA Margin (%)29.1329.8523.5631.2735.45
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Return on Equity (%)25.2923.6417.2122.7123.41
      Return on Capital Employed (%)30.8230.7620.7527.4730.13
      Return on Assets (%)20.1319.1412.9719.0419.12
      Interest Coverage Ratio (x)287.95181.75159.09113.01147.90
      Asset Turnover Ratio (x)0.990.930.840.860.83
      Price to Earnings (x)35.8435.0927.4021.6023.09
      Price to Book (x)9.058.284.714.905.40
      EV/EBITDA (x)24.7422.8318.0314.9315.13
      EBITDA Margin (%)30.6431.1224.3932.8137.53

    Financial InsightsAjanta Pharma

    • Income (P&L)

      • Employee & Interest Expense

        Company has spent less than 1% of its operating revenues towards interest expenses and 23.44% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Ajanta Pharma Share Price Forecast

    • Get multiple analysts’ prediction on Ajanta Pharma

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL

    • Get multiple analysts’ prediction on Ajanta Pharma

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL

    • Get multiple analysts’ prediction on Ajanta Pharma

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL

    Ajanta Pharma Technicals

    • Bullish / Bearish signals for Ajanta Pharma basis selected technical indicators and moving average crossovers.

      20 Day EMA Crossover

      Bullish signal on daily chart

      Appeared on:

    Ajanta Pharma Peer Comparison

      • CHART
      • TABLE

      • Choose from Peers

          Choose from Stocks

          • 1D
          • 1W
          • 1M
          • 3M
          • 6M
          • 1Y
          • 5Y
          Loading...

        • Ratio Performance

          NAMEP/E (x)P/B (x)ROE %ROCE %ROA %Rev CAGR [3Yr]OPMNPMBasic EPSCurrent RatioTotal Debt/ Equity (x)Total Debt/ CFO (x)
          Ajanta Pharma35.198.5424.2830.1018.3511.0026.0219.8073.562.850.000.00
          Glenmark Pharma-227.475.10-19.1317.01-10.454.7512.30-12.13-53.221.280.13-3.73
          Ipca Labs48.844.618.6412.444.9312.4814.126.8625.822.350.221.47
          Laurus Labs89.586.978.0112.083.834.3412.606.386.651.220.604.48
          Piramal Pharma312.553.601.126.400.5810.648.340.190.691.540.585.29
          Add More
          Annual Ratios (%)

          Choose from Peers

          • Suven Pharma
          • Syngene Int.
          • J B Chemicals
          • Gland Pharma
          • Wockhardt

          Choose from Stocks

            See All Parameters

          Peers InsightsAjanta Pharma

            Do you find these insights useful?

            • hate it

            • meh

            • love it

            Ajanta Pharma Shareholding Pattern

            • Loading...
              Showing Ajanta Pharma Shareholding as on Mar 2025
              CategoryMar 2025Dec 2024Sep 2024Jun 2024
              Promoters66.2666.2666.2666.27
              Pledge12.6111.1711.1711.57
              FII8.869.269.118.36
              DII17.4817.0217.0917.41
              Mutual Funds15.1314.8914.9314.84
              Others7.397.457.537.96
            • Showing Shareholding as on Mar 2025
              CategoryNo. of SharesPercentage% Change QoQ
              Promoters8,27,63,77766.26 %0.00
              Pledge1,04,37,64412.61 %1.43
              FII1,10,70,9278.86 %-0.40
              DII2,18,37,04517.48 %0.46
              MF1,88,96,92215.13 %0.24
              Others92,40,3507.39 %-0.06

            Ajanta Pharma MF Ownership

            MF Ownership as on 30 April 2025

            View all Mutual Fund Schemes
            Top Searches:
            Ajanta Pharma News Ajanta Pharma Quarterly Results Ajanta Pharma Dividend Ajanta Pharma Q1 ResultsAjanta Pharma Q2 ResultsAjanta Pharma Q3 ResultsAjanta Pharma Q4 Results

            Ajanta Pharma Corporate Actions

            • Meeting DateAnnounced onPurposeDetails
              Apr 30, 2025Apr 22, 2025Board MeetingAudited Results & A.G.M.
              Jan 30, 2025Jan 17, 2025Board MeetingQuarterly Results
              Oct 28, 2024Oct 17, 2024Board MeetingQuarterly Results
              Jul 30, 2024Jul 18, 2024Board MeetingQuarterly Results
              Jul 18, 2024Jun 14, 2024AGM-
            • TypeDividendDividend per ShareEx-Dividend DateAnnounced on
              Interim1400%28.0Nov 06, 2024Oct 25, 2024
              Interim1300%26.0Feb 08, 2024Jan 25, 2024
              Interim500%10.0Aug 04, 2023Jul 25, 2023
              Interim0%0.0Aug 04, 2023Jul 24, 2023
              Special750%15.0Aug 04, 2023Jul 24, 2023
            • All TypesEx-DateRecord DateAnnounced onDetails
              BonusJun 22, 2022Jun 23, 2022May 10, 2022Bonus Ratio: 1 share(s) for every 2 shares held
              SplitsMar 20, 2015Mar 23, 2015Jan 28, 2015Split: Old FV5.0| New FV:2.0
              BonusSep 17, 2013Sep 18, 2013Jul 29, 2013Bonus Ratio: 1 share(s) for every 2 shares held
              SplitsAug 09, 2012Aug 10, 2012Apr 26, 2012Split: Old FV10.0| New FV:5.0
              Bonus--May 05, 2014Bonus Ratio: 1 share(s) for every 2 shares held

            About Ajanta Pharma

            Ajanta Pharma Ltd., incorporated in the year 1979, is a Mid Cap company (having a market cap of Rs 32,385.96 Crore) operating in Pharmaceuticals sector. Ajanta Pharma Ltd. key Products/Revenue Segments include Pharmaceutical Products, Export Incentives and Other Operating Revenue for the year ending 31-Mar-2024. Show More

            • Executives

            • Auditors

            • MB

              Mannalal B Agrawal

              Chairman
              MB

              Madhusudan B Agrawal

              Vice Chairman
              YM

              Yogesh M Agrawal

              Managing Director
              RM

              Rajesh M Agrawal

              Joint Managing Director
              Show More
            • B S R & Co. LLP

            Industry

            Pharma - Indian

            Key Indices Listed on

            Nifty 500, BSE 500, Nifty Pharma, + 18 more

            Address

            Ajanta House,Charkop,Kandivli (West),Mumbai, Maharashtra - 400067

            Contact

            [email protected]

            http://www.ajantapharma.com

            More Details

            FAQs about Ajanta Pharma share

            • 1. What's Ajanta Pharma share price today and what are Ajanta Pharma share returns ?
              Ajanta Pharma share price is Rs 2,603.60 as on 16 May, 2025, 03:59 PM IST. Ajanta Pharma share price is up by 0.19% based on previous share price of Rs. 2586.3. In last 1 Month, Ajanta Pharma share price moved down by 1.19%.
            • 2. Who owns Ajanta Pharma?
                • Promoter holding have gone down from 66.27 (30 Jun 2024) to 66.26 (31 Mar 2025)
                • Domestic Institutional Investors holding has gone up from 17.41 (30 Jun 2024) to 17.48 (31 Mar 2025)
                • Foreign Institutional Investors holding has gone up from 8.36 (30 Jun 2024) to 8.86 (31 Mar 2025)
                • Other investor holding have gone down from 7.96 (30 Jun 2024) to 7.39 (31 Mar 2025)
            • 3. Is Ajanta Pharma giving dividend?
              Ajanta Pharma Ltd. announced an equity dividend of 1400% on a face value of 2.0 amounting to Rs 28 per share on 25 Oct 2024. The ex dividend date was 06 Nov 2024.
            • 4. What is the market cap of Ajanta Pharma?
              Ajanta Pharma share has a market capitalization of Rs 32,385.96 Cr. Within Pharmaceuticals sector, it's market cap rank is 16.
            • 5. What is 52 week high/low of Ajanta Pharma share price?
              52 Week high of Ajanta Pharma share is Rs 3,485.00 while 52 week low is Rs 2,111.05
            • 6. What are the returns for Ajanta Pharma share?
              Return Performance of Ajanta Pharma Shares:
              • 1 Week: Ajanta Pharma share price moved up by 2.59%
              • 1 Month: Ajanta Pharma share price moved down by 1.19%
            • 7. What are the Ajanta Pharma quarterly results?
              On Consoldiated basis, Ajanta Pharma reported a total income and profit of Rs 1188.52 Cr and Rs 225.26 respectively for quarter ending 2025-03-31. Total Income and profit for the year ending 2025-03-31 was Rs 4742.60 Cr and Rs 920.39 Cr.
            • 8. Which are the key peers to Ajanta Pharma?
              Top 10 Peers for Ajanta Pharma are Laurus Labs Ltd., Piramal Pharma Ltd., Syngene International Ltd., Suven Pharmaceuticals Ltd., Ipca Laboratories Ltd., Wockhardt Ltd., J B Chemicals & Pharmaceuticals Ltd., Glenmark Pharmaceuticals Ltd., Gland Pharma Ltd. and Concord Biotech Ltd.
            • 9. What is the PE & PB ratio of Ajanta Pharma?
              The PE ratio of Ajanta Pharma stands at 35.27, while the PB ratio is 8.59.
            • 10. Who's the chairman of Ajanta Pharma?
              Mannalal B Agrawal is the Chairman of Ajanta Pharma
            • 11. How can I quickly analyze Ajanta Pharma stock?
              Ajanta Pharma share can be quickly analyzed on following metrics:
              • Stock's PE is 35.19
              • Price to Book Ratio of 8.54
            • 12. What is the CAGR of Ajanta Pharma?
              The CAGR of Ajanta Pharma is 8.61.

            Trending in Markets

            Top Gainers As on 03:59 PM | 16 May 2025

            IFCI51.77
            7.03 (15.69%)
            Rites286.99
            38.74 (15.61%)
            Titagarh Wagons912.85
            103.81 (12.83%)
            Cochin Shipyard2,035.60
            223.50 (12.34%)
            Mazagon Dock Ship3,522.40
            340.00 (10.69%)

            Top Losers As on 03:59 PM | 16 May 2025

            Neuland Labs11,056.00
            -803.00 (-6.78%)
            Glenmark Life1,142.60
            -63.41 (-5.26%)
            Godfrey Philips8,718.50
            -458.50 (-5.00%)
            Global Health1,201.10
            -42.21 (-3.40%)
            JSW Infrastructure288.25
            -8.81 (-2.97%)

            DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

            DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

            By using this site, you agree to the Terms of Service and Privacy Policy.

            Business News›Markets›Stocks›Stock Price Quotes›Ajanta Pharma Share Price
            The Economic Times
            BrowseCompanies:
            OSZAR »